Global guideline for the diagnosis and management of rare yeast
infections: an initiative of the ECMM in cooperation with ISHAM
and ASM

J 2021

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL et. al.

Basic information

Original name

Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

Authors

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER (203 Czech Republic, belonging to the institution), C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI and N. P. GOVENDER

Edition

Lancet Infectious Diseases, Oxford, Elsevier SCI LTD, 2021, 1473-3099

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30303 Infectious Diseases

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 71.421

RIV identification code

RIV/00216224:14110/21:00123979

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/S1473-3099(21)00203-6

UT WoS

000723373700002

Keywords in English

rare yeast infections; diagnosis; management

Abstract

V originále

Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma (ie, now Moesziomyces or Dirkmeia), Rhodotorula, Saccharomyces, and Sporobolomyces (ie, ascomycetes). A considered approach to the complex, multidisciplinary management of infections that are caused by these pathogens is essential to optimising patient outcomes; however, management guidelines are either region-specific or require updating. In alignment with the One World-One Guideline initiative to incorporate regional differences, experts from diverse geographical regions analysed publications describing the epidemiology and management of the previously mentioned rare yeasts. This guideline summarises the consensus recommendations with regards to the diagnostic and therapeutic options for patients with these rare yeast infections, with the intent of providing practical assistance in clinical decision making. Because there is less clinical experience of patients with rare yeast infections and studies on these patients were not randomised, nor were groups compared, most recommendations are not robust in their validation but represent insights by use of expert opinions and in-vitro susceptibility results. In this Review, we report the key features of the epidemiology, diagnosis, antifungal susceptibility, and treatment outcomes of patients with Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon spp infections.

Citovat

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER, C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI and N. P. GOVENDER. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infectious Diseases. Oxford: Elsevier SCI LTD, 2021, vol. 21, No 12, p. "E375"-"E386", 12 pp. ISSN 1473-3099. Available from: https://dx.doi.org/10.1016/S1473-3099(21)00203-6.

@article{1828120,
   author = {Chen, S. C. A. and Perfect, J. and Colombo, A. L. and Cornely, O. A. and Groll, A. H. and Seidel, D. and Albus, K. and de Almedia, J. N. and GarciaandEffron, G. and Gilroy, N. and LassandFlorl, C. and OstroskyandZeichner, L. and Pagano, L. and Papp, T. and RautemaaandRichardson, R. and SalmantonandGarcia, J. and Spec, A. and Steinmann, J. and ArikanandAkdagli, S. and Arenz, D. E. and Sprute, R. and DuranandGraeff, L. and Freiberger, Tomáš and Girmenia, C. and Harris, M. and Kanj, S. S. and Roudbary, M. and Lortholary, O. and Meletiadis, J. and Segal, E. and Tuon, F. F. and Wiederhold, N. and Bicanic, T. and Chander, J. and Chen, Y. C. and Hsueh, P. R. and Ip, M. and Munoz, P. and Spriet, I. and Temfack, E. and Thompson, L. and Tortorano, A. M. and Velegraki, A. and Govender, N. P.},
   article_location = {Oxford},
   article_number = {12},
   doi = {http://dx.doi.org/10.1016/S1473-3099(21)00203-6},
   keywords = {rare yeast infections; diagnosis; management},
   language = {eng},
   issn = {1473-3099},
   journal = {Lancet Infectious Diseases},
   title = {Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM},
   url = {https://www.sciencedirect.com/science/article/pii/S1473309921002036?via%3Dihub},
   volume = {21},
   year = {2021}
}

TY  - JOUR
ID  - 1828120
AU  - Chen, S. C. A. - Perfect, J. - Colombo, A. L. - Cornely, O. A. - Groll, A. H. - Seidel, D. - Albus, K. - de Almedia, J. N. - Garcia-Effron, G. - Gilroy, N. - Lass-Florl, C. - Ostrosky-Zeichner, L. - Pagano, L. - Papp, T. - Rautemaa-Richardson, R. - Salmanton-Garcia, J. - Spec, A. - Steinmann, J. - Arikan-Akdagli, S. - Arenz, D. E. - Sprute, R. - Duran-Graeff, L. - Freiberger, Tomáš - Girmenia, C. - Harris, M. - Kanj, S. S. - Roudbary, M. - Lortholary, O. - Meletiadis, J. - Segal, E. - Tuon, F. F. - Wiederhold, N. - Bicanic, T. - Chander, J. - Chen, Y. C. - Hsueh, P. R. - Ip, M. - Munoz, P. - Spriet, I. - Temfack, E. - Thompson, L. - Tortorano, A. M. - Velegraki, A. - Govender, N. P.
PY  - 2021
TI  - Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
JF  - Lancet Infectious Diseases
VL  - 21
IS  - 12
SP  - "E375"-"E386"
EP  - "E375"-"E386"
PB  - Elsevier SCI LTD
SN  - 14733099
KW  - rare yeast infections
KW  - diagnosis
KW  - management
UR  - https://www.sciencedirect.com/science/article/pii/S1473309921002036?via%3Dihub
N2  - Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients who are immunocompromised or seriously ill. The major pathogens include those of the genera Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon (ie, basidiomycetes) and Kodamaea, Malassezia, Pseudozyma (ie, now Moesziomyces or Dirkmeia), Rhodotorula, Saccharomyces, and Sporobolomyces (ie, ascomycetes). A considered approach to the complex, multidisciplinary management of infections that are caused by these pathogens is essential to optimising patient outcomes; however, management guidelines are either region-specific or require updating. In alignment with the One World-One Guideline initiative to incorporate regional differences, experts from diverse geographical regions analysed publications describing the epidemiology and management of the previously mentioned rare yeasts. This guideline summarises the consensus recommendations with regards to the diagnostic and therapeutic options for patients with these rare yeast infections, with the intent of providing practical assistance in clinical decision making. Because there is less clinical experience of patients with rare yeast infections and studies on these patients were not randomised, nor were groups compared, most recommendations are not robust in their validation but represent insights by use of expert opinions and in-vitro susceptibility results. In this Review, we report the key features of the epidemiology, diagnosis, antifungal susceptibility, and treatment outcomes of patients with Geotrichum, Saprochaete, Magnusiomyces, and Trichosporon spp infections.
ER  -

CHEN, S. C. A., J. PERFECT, A. L. COLOMBO, O. A. CORNELY, A. H. GROLL, D. SEIDEL, K. ALBUS, J. N. DE ALMEDIA, G. GARCIA-EFFRON, N. GILROY, C. LASS-FLORL, L. OSTROSKY-ZEICHNER, L. PAGANO, T. PAPP, R. RAUTEMAA-RICHARDSON, J. SALMANTON-GARCIA, A. SPEC, J. STEINMANN, S. ARIKAN-AKDAGLI, D. E. ARENZ, R. SPRUTE, L. DURAN-GRAEFF, Tomáš FREIBERGER, C. GIRMENIA, M. HARRIS, S. S. KANJ, M. ROUDBARY, O. LORTHOLARY, J. MELETIADIS, E. SEGAL, F. F. TUON, N. WIEDERHOLD, T. BICANIC, J. CHANDER, Y. C. CHEN, P. R. HSUEH, M. IP, P. MUNOZ, I. SPRIET, E. TEMFACK, L. THOMPSON, A. M. TORTORANO, A. VELEGRAKI and N. P. GOVENDER. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. \textit{Lancet Infectious Diseases}. Oxford: Elsevier SCI LTD, 2021, vol.~21, No~12, p.~''E375''-''E386'', 12 pp. ISSN~1473-3099. Available from: https://dx.doi.org/10.1016/S1473-3099(21)00203-6.

Detailed Information on Publication Record